These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16498369)

  • 1. Cardiovascular disease after menopause: a growing epidemic.
    Alexander J; Clearfield M
    Minerva Ginecol; 2006 Feb; 58(1):35-40. PubMed ID: 16498369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing cardiovascular risk in menopausal women.
    Rosano GM; Vitale C; Tulli A
    Climacteric; 2006 Sep; 9 Suppl 1():19-27. PubMed ID: 16899440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and the menopause.
    Kaaja RJ
    Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular disease as a current threat of older women. Relation to estrogens].
    Zárate A; Saucedo R; Basurto L; Martínez C
    Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can menopause be considered an independent risk factor for cardiovascular disease?
    Mercuro G; Zoncu S; Cherchi A; Rosano GM
    Ital Heart J; 2001 Oct; 2(10):719-27. PubMed ID: 11721715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Should all menopausal women have hormone replacement therapy for the prevention of coronary disease?].
    Neves-e-Castro M
    Rev Port Cardiol; 1999 Nov; 18(11):1039-43. PubMed ID: 10608164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome among postmenopausal women in Ecuador.
    Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
    Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause and cardiovascular disease.
    Philosophe R; Seibel MM
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1991; 2(4):441-51. PubMed ID: 1772731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation critique of state of the art dyslipidemia management in general and with a special emphasis on the Indian population.
    Whayne TF
    Indian Heart J; 2007; 59(3):218-25. PubMed ID: 19124929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001.
    Kim HM; Park J; Ryu SY; Kim J
    Diabetes Care; 2007 Mar; 30(3):701-6. PubMed ID: 17327344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality.
    Ho JS; Cannaday JJ; Barlow CE; Mitchell TL; Cooper KH; FitzGerald SJ
    Am J Cardiol; 2008 Sep; 102(6):689-92. PubMed ID: 18773989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    Vitale C; Miceli M; Rosano GM
    Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
    Maturana MA; Breda V; Lhullier F; Spritzer PM
    Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular morbidity and mortality of the metabolic syndrome.
    Obunai K; Jani S; Dangas GD
    Med Clin North Am; 2007 Nov; 91(6):1169-84, x. PubMed ID: 17964915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome.
    Cho GJ; Lee JH; Park HT; Shin JH; Hong SC; Kim T; Hur JY; Lee KW; Park YK; Kim SH
    Menopause; 2008; 15(3):524-9. PubMed ID: 18467953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.